Rezamid
NDC Package 11086-022-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Rezamid is shake very well before usingclean the skin thoroughly before applying this productcover the entire affected area with a thin layer one to three times dailybecause excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctorif bothersome dryness or peeling occurs, reduce application to once a day or every other day. Marketed by Summers Laboratories Inc, this product is identified by NDC 11086-022 and is authorized under FDA application M032.

Identification & Billing

NDC Package Code
11086-022-01
Package Description
56.7 mL in 1 BOTTLE
Product Code
11086-022
11-Digit Billing Format
11086002201
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Rezamid
Dosage Form
-
Usage Information
Shake very well before usingclean the skin thoroughly before applying this productcover the entire affected area with a thin layer one to three times dailybecause excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctorif bothersome dryness or peeling occurs, reduce application to once a day or every other day

Regulatory & Marketing

Labeler Name
Summers Laboratories Inc
FDA Application #
M032
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
10-30-2013
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 11086-022-01 identifies a specific commercial package of 56.7 ml in 1 bottle of Rezamid, labeled by Summers Laboratories Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Summers Laboratories Inc on October 30, 2013. The current certification is valid through December 31, 2024.

How is this Summers Laboratories Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 11086002201. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
11086-022-01
11-Digit CMS (5-4-2)
11086-0022-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.